Canada Numinus set to open Canada’s first psychedelics neurology centre The Vancouver based firm is acquiring the Neurology Centre of Toronto in a cash and stock deal Natalia Buendia CalvilloJuly 7, 2021
News More Canadians, Americans open to psychedelic therapy, surveys show Toronto-based Field Trip launched two new polls that show more people are open to using psychedelics to treat rising pandemic-related mental health issues Jared GnamMay 20, 2021
Culture Becoming light through the darkness: My first ibogaine trip Writer Suzannah Weiss details her experience of physical and mental healing, accompanied by comic illustrations Suzannah WeissMay 14, 2021
News 67% of PTSD sufferers drop diagnosis in first MDMA Phase 3 trial Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA Natalia Buendia CalvilloMay 4, 2021
Industry update Canada’s first set of approved health workers begin psilocybin therapy training 15 trainees started a beta program this week, designed and run by advocacy group TheraPsil Natalia Buendia CalvilloMarch 2, 2021
Analysis Field Trip white paper makes strong health and business case for ketamine therapy With solid efficacy and low cost, the popular club drug could help curb the personal toll and multi-billion dollar cost of North America's battle... Natalia Buendia CalvilloFebruary 9, 2021
Canada Proposed amendment could greatly expand access to psychedelic therapy in Canada Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program Natalia Buendia CalvilloJanuary 28, 2021
Health and Safety What Measure 109 means for the future of psychedelic therapy After a successful ballot measure, a broad set of onlookers focuses on Oregon to gauge the social and economic impacts of licensed psilocybin therapy Amna ShamimDecember 15, 2020
The weed wire UC Berkeley’s new psychedelic research centre wants to change your mind The new hub will focus on the rapidly advancing field by adding unique public education and spiritual components Jared GnamSeptember 16, 2020
The weed wire Mushroom company Mydecine acquires veteran-focused psychedelic firm With deep Canadian and U.S. military ties, NeuroPharm Inc. is about to launch psychedelic-based clinical trials Jared GnamJuly 15, 2020